Answer
Bleeding is the most common complication of tenecteplase treatment for acute myocardial infarction, most frequently occurring at the injection site.
Sources for this answer
- Metalyse 10,000 unitsBoehringer Ingelheim Limited · emc · SmPC §4.4 Special warnings and precautions for use · Version 10Document updated
Sources checked